Background: MicroRNAs (miRNAs) regulate various biological processes through inhibiting the translation of RNA transcripts. Although miRNA-1 (miR-1) and miRNA-133 (miR-133) are abundantly expressed in the adult heart and involved in cardiac hypertrophy, the roles of these miRNAs in spontaneous myocardial differentiation are unknown.
icroRNAs (miRNAs) are a class of 17-25 nt noncoding small RNAs that mediate post-transcriptional gene repression by inhibiting protein translation or destabilizing the RNA transcripts of the target genes. [1] [2] [3] [4] [5] Commonly, miRNAs recognize the 3' untranslated regions (UTRs) as target sites, and undergo paring there to silence transcripts. This mechanism plays an essential role in various biological processes, including the self-renewal and differentiation of embryonic stem (ES) cells. [6] [7] [8] [9] [10] [11] [12] [13] To investigate the precise roles of miRNAs during the myocardial differentiation of ES cells, we focused on 3 miRNAs, miR-1, miR-133 and miR-143, which are strongly expressed in the adult heart. 14-16 miR-1 and miR-133 are also expressed in skeletal muscles and play differential roles. Although miR-1 promotes myoblast differentiation by targeting histone deacetylase 4 (HDAC4), miR-133 mediates myoblast proliferation through targeting serum response factor (SRF) in C2C12 cells. 15 In cardiac myocytes, miR-1 and miR-133 regulate hypertrophic responses. [17] [18] [19] In this process, cyclin-dependent kinase-9 (Cdk9) is 1 of the target genes of miR-1. 18, 19 Recently, Ivey et al reported that miR-1 promotes and miR-133 blocks myocardial differentiation during embryoid body (EB)-based culture of mouse and human ES cells. 20 However, the roles of miR-1 and miR-133 in spontaneous myocardial differentiation of ES cells by 2-dimensional (D) culture are yet to be determined.
Editorial p 1397
Previously, we reported that trichostatin A (TSA), an inhibitor of histone deacetylase, enhances the myocardial differentiation of mouse and monkey ES cells through acetylating histone and a transcription factor, GATA4. 21, 22 GATA4 promotes the expression of cardiac genes, such as Nkx2.5, atrial natriuretic factor (ANF), and β-myosin heavy chain (β-MHC), by forming a transcriptional complex with its coactivators, p300 and Cdk9. 23 The kinase activity of Cdk9 plays an important role in the p300-induced GATA4 acetylation, and, finally, the myocardial differentiation of mouse ES cells. 24 In the present study, we investigated the expression profiles of miR-1, miR-133, and miR-143 during the myocardial differentiation of 2-D cultured mouse ES cells, and found that all of these miRNAs were increased during spontaneous differentiation, but reduced during TSA-induced myocardial differentiation. The overexpression of miR-1 or miR-133, but not that of miR-143, inhibited the expression of cardiac genes. miR-1 post-transcriptionally inhibited Cdk9 translation in ES cells, suggesting that miR-1 regulates the myocardial differentiation of ES cells, in part, by downregulating Cdk9.
Methods

Cell Line and Culture of Mouse ES Cells
The 129/Ola-derived ES cell line, ht7, was maintained as previously described. 21, 25 The state of undifferentiated ES cells was defined as day 0. To induce differentiation, undifferentiated ES cells were plated and 2-D cultured on gelatinized dishes without leukemia-inhibitory factor, feeder cells or the formation of EBs. To enhance myocardial differentiation, the cells were stimulated with TSA at day 7 after the induction of differentiation for 24 h.
Plasmid Constructs
pGFP::miR plasmids are lentivirus vectors that simultaneously express EGFP and a pre-miRNA transcript under the phosphoglycerate kinase (PGK) promoter. pGFP::miRcontrol, pGFP::miR-1, pGFP::miR-133, and pGFP::miR-143 were constructed as follows. Pre-miRNA oligonucleotides were annealed and subcloned into pcDNA™ 6.2-GW/ EmGFP-miR (Invitrogen). Next, the fragments containing EGFP::pre-miRNA sequences were inserted into a lentivirus vector, pLenti6/V5-D-TOPO ® (Invitrogen). Subsequently, the promoter of these plasmids was substituted with the PGK promoter. The inserted oligonucleotide sequences (5' to 3') were as follows: (mature miRNA sequences are shown in uppercase): miR-control, which is predicted not to target any known vertebrate gene (Invitrogen), GAA ATG TAC TGC GCG TGG AGA Cgt ttt ggc cac tga ctg acG TCT CCA CGC AGT ACA TTT; miR-1, TGG AAT GTA AAG AAG TAT GTA gtt ttg gcc act gac tga cTA CAT ACT TTT ACA TTC CA; miR-133, TTG GTC CCC TTC AAC CAG CTA gtt ttg gcc act gac tga cTA GCA GGT TGA AGG GGA CCA A; and miR-143, TGA GAT GAA GCA CTG TAG CTC Agt ttt ggc cac tga ctg acT GAG CTA CAG TGC TTC ATC TCA.
pLuc::Cdk9-UTR, pLuc::HDAC4-UTR, and pLuc::SRF-UTR plasmids, respectively, consist of the firefly luciferase cDNA with the 3' UTRs of Cdk9, HDAC4, and SRF, which were constructed by inserting 3' UTR fragments into the pMIR-REPORT™ Luciferase vector (Applied Biosystems). Total RNA from ES cells used in the present study was reverse transcribed, and the 3' UTRs of Cdk9, HDAC4, and SRF were amplified using primers as follows (5' to 3'): Cdk9, GAA TTT GAA CTA GTC TTC TGA GG (sense) and AAA ATA ACA AGC TTT TAA TTT AAC C (antisense); HDAC4, AGG AAC CAC TAG TGT AGC CCG AA (sense) and TAA GCT GTG AGC TCC CAC AGC A (antisense); SRF, ACA GCA CCA CTA GTG AAT GAT (sense) and CAA ATA AAA AGC TTA AAA TCA ACT C (antisense). pRL-SV40 (TOYO B-Net) contains the sea pansy luciferase cDNA driven by a simian virus 40 promoter. pCMVβ-gal (Santa Cruz Biotechnology) contains the β-galactosidase cDNA driven by a cytomegalovirus promoter.
Lentiviral Infection and Flow Cytometry
Recombinant lentiviral stocks and virus-containing medium were prepared as previously described. 26 For infection, undifferentiated ES cells were plated on gelatinized dishes with virus-containing medium and cultured for 24 h. Infected cells were visualized as GFP-positive cells by flow cytometry (FACS Canto, BD Biosciences), as previously described. 21 
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Total RNAs from ES cells were isolated using TRIzol ® Reagent (Invitrogen), and treated with DNase I to eliminate genomic DNA. 27 For detecting miRNAs, 20 ng of each total RNA was reverse transcribed and amplified using the mirVana™ qRT-PCR miRNA Detection Kit (Ambion), mature miRNA-specific primers (Ambion), and SuperTaq™ DNA polymerase (Applied Biosystems). Amplified products were analyzed on ethidium bromide-stained 3.5% agarose gels. For gene expression analyses, total RNAs were reverse transcribed, amplified, and quantified by real-time RT-PCR, as previously described. 21 Primer sequences of Nkx2.5, α-MHC, and ANF have been previously described. 25 Primer sequences from 5' to 3' of Cdk9 were ACG GCC TCT ACT ACA TCC ACA (sense) and GCT ACG AGT CCA CAT CTC TGC (antisense).
Transfection and Dual-Luciferase Assay
For dual-luciferase assays, undifferentiated ES cells were transfected with DNA in serum-free medium using Lipofectamine™ LTX with PLUS Reagents (Invitrogen). The total DNA content in each sample was standardized with pCMVβ-gal. The cells were lysed after 48 h of transfection. The activities of firefly and sea pansy luciferase were measured in the same cell lysate using the PicaGene ® Dual kit (TOYO B-Net). The relative luciferase activities were calculated as the ratio of firefly to sea pansy luciferase. Each experiment was carried out in duplicate.
Western Blotting
Nuclear extracts of lentiviral-infected ES cells were prepared and subjected to western blotting as described previously 21 using rabbit polyclonal anti-Cdk9 (Santa Cruz Biotechnology) and mouse monoclonal anti-β-actin (Sigma) antibodies.
Statistical Analysis
The results are presented as means ± standard errors. Statistical comparisons were performed using unpaired 2-tailed Student's t-tests or ANOVA with Scheffe's test where appropriate, 28 with a probability value <0.05 taken to indicate significance.
Results
Expression Profiles of Cardiac miRNAs During Differentiation of ES Cells
First, we examined the expression profiles of miRNAs during the myocardial differentiation of mouse ES cells. To induce differentiation, undifferentiated ES cells were plated and 2-D cultured on gelatinized dishes. RT-PCR analyses demonstrated that small amounts of mature miR-1, miR-133, and miR-143 were expressed in undifferentiated ES cells ( Figure 1A, day 0) . The levels of these miRNAs increased after the induction of differentiation in a time-dependent manner ( Figure 1A, days 3-8) . We previously reported that TSA, a histone deacetylase inhibitor, enhances the differentiation of mouse and monkey ES cells into cardiac myocytes. 21, 22, 24 As shown in Figure 1B , TSA dose-dependently reduced the levels of the cardiac miRNAs, miR-1, miR-133, and miR-143. However, TSA did not affect the level of miR-24, which is ubiquitously expressed in various tissues.
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These results demonstrate that TSA-induced myocardial differentiation reduces the expression of cardiac miRNAs, miR-1, miR-133, and miR-143, in ES cells.
miR-1 and miR-133 Repress Myocardial Differentiation of ES Cells
To investigate the roles of cardiac miRNAs during myocardial differentiation, we overexpressed miR-1, miR-133, or miR-143 in ES cells. Each miRNA expression vector, which simultaneously expresses GFP and miRNA, was introduced into undifferentiated ES cells by lentiviral infection and the infected cells were induced to differentiate. Flow cytometry analysis indicated that nearly 90% of infected ES cells expressed GFP at day 8 after the induction of differentia- tion (Figure 2A) . We confirmed by RT-PCR that mature miRNAs were actually overexpressed ( Figure 2B) . Then, we quantified the mRNA levels of cardiac-specific genes, Nkx2.5, α-MHC and ANF, by real-time RT-PCR. The overexpression of miR-1 or miR-133 significantly downregulated the transcripts of Nkx2.5 during the spontaneous differentiation of ES cells (Figure 2C ). In addition, miR-1 markedly reduced the mRNA levels of α-MHC (Figure 2D) . Although there were no significant differences, miR-133 appeared to inhibit α-MHC expression, and miR-1 or miR-133 tended to reduce ANF expression (Figures 2D,E) . In contrast, the overexpression of miR-143 did not affect the cardiac gene expression at all. These results indicate that miR-1 and miR-133 suppress the myocardial differentiation of ES cells.
Target of miR-1 in ES Cells
To determine whether Cdk9, HDAC4, and SRF are miRNA-targeted genes in ES cells, we constructed reporter plasmids that express luciferase mRNA fused with the 3' UTRs of Cdk9, HDAC4 or SRF ( Figure 3A) . As shown in Figure 3B , coexpression of miR-1, but not that of miR-133 or 144, reduced the activity of luciferase derived from the Cdk9-3' UTR plasmid. However, none of these miRNAs affected the luciferase activity derived from the HDAC4-or SRF-3' UTR plasmid (Figures 3C,D) . To investigate whether miR-1 inhibits the translation of endogenous Cdk9, we examined the protein and mRNA levels of Cdk9 in ES cells overexpressing miR-1. As shown in Figure 4A , the levels of Cdk9 protein were decreased in ES cells over- expressing miR-1 compared with those expressing control miRNA. In contrast, the mRNA levels of Cdk9 were not affected by overexpressing miR-1 ( Figure 4B) . These results indicate that miR-1 post-transcriptionally inhibits Cdk9 translation by targeting the 3' UTR of Cdk9 mRNA in ES cells.
Discussion
The present study investigated the regulated expression of cardiac miRNAs, miR-1, miR-133, and miR-143, during the cardiac differentiation of mouse ES cells. The levels of these miRNAs in ES cells were increased during their spontaneous myocardial differentiation by 2-D culture, but reduced during TSA-induced differentiation. Furthermore, we demonstrated that the forced expression of miR-1 or miR-133 using lentiviral vectors in ES cells suppressed cardiac gene expression during their differentiation. The precise mechanisms by which TSA reduces cardiac miRNAs are unclear at present. However, in cardiomyocytes, it has been reported that the levels of endogenous miR-1 and miR-133 are decreased during myocardial cell hypertrophy, and that the forced expression of miR-1 or miR-133 suppresses hypertrophic responses. 17, 18 Our data obtained using ES cells are compatible with those results in cardiomyocytes. It is possible that the TSA-induced decrease in miR-1 and miR-133, in part, contributes to the enhancement of myocardial differentiation. By contrast, in spontaneously differentiating ES cells, increased miR-1 and miR-133 levels may be involved in the inhibition of myocardial differentiation as a negative feed-back loop. These findings suggest that the regulated expression of miR-1 and miR-133 in mouse ES cells plays a distinct role in artificial myocardial differentiation by TSA and spontaneous differentiation. The precise roles of these miRNAs during myocardial differentiation should be clarified by further studies.
Luciferase assays revealed that miR-1 recognizes and targets the 3' UTR of Cdk9. The results of western blotting and real-time RT-PCR demostrated that miR-1 post-transcriptionally inhibits Cdk9 translation. These findings indicate that miR-1 regulates the myocardial differentiation of ES cells, in part, by downregulating Cdk9. It has been reported that miR-1 suppresses myocardial cell hypertrophy by targeting Cdk9 in cardiac myocytes. 18, 19 Recently, we found that Cdk9 forms a transcriptional complex with p300/GATA4, to activate the expression of cardiac-specific genes such as Nkx2.5, ANF, and β-MHC. 23, 24 The kinase activity of Cdk9 is required for the acetylation of GATA4 and for the myocardial differentiation of mouse ES cells. The administration of Cdk9 inhibitor or the forced expression of the dominant-negative form of Cdk9 suppresses cardiac gene transcription and the myocardial differentiation of mouse ES cells cultured, 24 as noted in the present study. Therefore, it is possible that the miR-1-dependent decrease of Cdk9 protein suppresses cardiac gene expression in ES cells during spontaneous differentiation.
Although not only miR-1, but also miR-133, repressed cardiac gene expression during the differentiation of ES cells, we could not identify the target genes of miR-133 in ES cells. In C2C12 cells, miR-1 targets HDAC4 and miR-133 targets SRF. 15 However, neither of these miRNAs appears to target HDAC4 or SRF in ES cells, suggesting the presence of differential mechanisms in miRNA-dependent inhibition between ES cells and other cell lines.
Our data are compatible with those in the report by Kwon et al showing that overexpression of miR-1 in mesoderm results in fewer myocardial cells. 29 In contrast, Ivey et al reported that overexpression of miR-1 promotes myocardial differentiation during EB-based culture of ES cells. They described that this effect by miR-1 is mediated by repressing Notch ligand Delta-like 1. 20 Notch signaling is initiated via ligand-receptor interactions on neighboring cells. Therefore, the discrepancy between our findings and those of Ivey et al may be attributable, in part, to the differences in cellto-cell interactions between 2-D culture and EB formation. In addition, the time course of gene expression is different between their system and ours. GATA4, which activates cardiac gene expression with Cdk9, begins to be expressed from day 5 in 2-D culture. 24 However, in an EB-forming system, a significant amount of GATA4 is expressed even on day 3. 21 Therefore, 2-D cultured ES cells, which express lower levels of GATA4, may be more sensitive to the minimal reduction of Cdk9 by miR-1 rather than the EBs expressing higher levels of GATA4.
The results obtained in this study suggest that miR-1 and miR-133 play important roles in the myocardial differentiation of ES cells by 2-D. These findings will be helpful in understanding the precise mechanisms of myocardial differentiation and for establishing future heart failure therapy targeting such miRNAs.
